NCT Number: NCT02167724
Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or
The aim of this study is to know the bucco-dental status of patients with schizophrenia in Côte d'Or.
Participation in this study will last only as long as it takes to:
* carry out a bucco-dental examination: evaluation of dental plaque and calculus * take a blood sample to assess needs in vitamin C (only for patients included at DIJON CHU and CHS Chartreuse) * complete a 30-minute questionnaire: clinical data and answers to questions concerning dental hygiene and eating habits.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
CHS La Chartreuse, Dijon, France
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients who have provided consent
- Patients over 18 years of age
- Persons with schizophrenia according to the ICD 10 criteria and followed in hospital (complete or day hospital) in one of the hospitals taking part in the study
Exclusion criteria
- Adult under guardianship
- Patient not covered by national health insurance
- Pregnant or breast-feeding women
- Patients not stabilized from a psychiatric viewpoint
- Patients experiencing an acute psychiatric episode
- Impossibility to understand and /or poor understanding of French
Treatment and study plan
blood sample
OtherClinical and social questionnaire
OtherPrimary outcomes
-
Calculate the DMF index (Decayed, Missing, Filled)
Time frame: Baselines
Secondary outcomes
-
Calculate the simplified Oral Health Index (OHI-S)
Time frame: Baselines
-
Perception of oral health of patients observed
Time frame: Baselines
Sponsors and collaborators
Lead sponsor
Centre Hospitalier Universitaire Dijon
Other
Registry information
Acronym: BUCCODOR
Important dates
- Study start
- 2014
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Jun 19, 2014
- Registry last updated
- Feb 9, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Metformin Treatment on Cognitive Impairment of Schizophrenia
NCT05838573
Cognition Disorders, Cognitive Dysfunction
Changsha, Hunan, China
View Trial DetailsAn Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
NCT05304767
Mental Disorders, Schizophrenia
Phoenix, Arizona, United States
View Trial DetailsMagnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
NCT00004571
Mental Disorders, Normal Physiology
Bethesda, Maryland, United States
View Trial DetailsTele-group Cognitive Behavioural Family Intervention for People With Schizophrenia and Their Families (Feasibility tgCBFI)
NCT05808244
Mental Disorders, Psychosis
Kowloon, Hong Kong
View Trial Details